SCHEMBL1820747

SCHEMBL1820747

CC(C)(C)C1CCC(OC(=O)OOOOC(=O)OC2CCC(C(C)(C)C)CC2)CC1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.47
APOBEC3A P31941 1/20 0.46
APOBEC3G Q9HC16 1/20 0.46
SMN1; SMN2 Q16637 3/20 0.45
HTT P42858 3/20 0.45
KDM4E B2RXH2 1/20 0.45
CYP19A1 P11511 1/20 0.44
NPC1 O15118 1/20 0.42
RAB9A P51151 1/20 0.42
GAA P10253 1/20 0.40
EPHX1 P07099 1/20 0.37
LIPA P38571 1/20 0.35
MEN1 O00255 3/20 0.33
KMT2A Q03164 3/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
GLA P06280 1/20 0.33
EPHX2 P34913 1/20 0.33
HSD11B1 P28845 1/20 0.33
TSHR P16473 1/20 0.31
NPSR1 Q6W5P4 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9482354 0.93 MAPT (0.43) MAPTAPOBEC3AAPOBEC3GSMN1; SMN2HTT
SCHEMBL35809 0.92 MAPT (0.50) MAPTAPOBEC3AAPOBEC3GSMN1; SMN2HTT
SCHEMBL11473642 0.90 MAPT (0.43) MAPTAPOBEC3AAPOBEC3GSMN1; SMN2HTT
SCHEMBL22733771 0.88 MAPT (0.53) MAPTAPOBEC3AAPOBEC3GSMN1; SMN2HTT
SCHEMBL2299719 0.87 MAPT (0.46) MAPTAPOBEC3AAPOBEC3GSMN1; SMN2HTT
SCHEMBL4652918 0.85 MAPT (0.45) MAPTAPOBEC3AAPOBEC3GSMN1; SMN2HTT
SCHEMBL5759240 0.85 MAPT (0.45) MAPTAPOBEC3AAPOBEC3GSMN1; SMN2HTT
SCHEMBL19594667 0.85 MAPT (0.45) MAPTAPOBEC3AAPOBEC3GSMN1; SMN2HTT
SCHEMBL321173 0.85 MAPT (0.45) MAPTAPOBEC3AAPOBEC3GSMN1; SMN2HTT
SCHEMBL8727040 0.84 MAPT (0.50) MAPTAPOBEC3AAPOBEC3GSMN1; SMN2HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 138 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4565670-A1 PROCESSES FOR PRODUCING RADICALLY-FUNCTIONALIZED PIBSA PRODUCT DERIVATIVES AND COMPOSITIONS COMPRISING SAME The Lubrizol Corporation (US) 2025-06-11 EP claimed
EP-4565669-A1 PROCESSES FOR PRODUCING REACTION PRODUCTS INCLUDING QUATERNARY AMMONIUM SALTS The Lubrizol Corporation (US) 2025-06-11 EP claimed
CN-118974149-A Open cell polymer foam composition with adjustable tortuosity and preparation method thereof 布拉斯科有限公司 2024-11-15 CN claimed
WO-2024030592-A1 PROCESSES FOR PRODUCING RADICALLY-FUNCTIONALIZED PIBSA PRODUCT DERIVATIVES AND COMPOSITIONS COMPRISING SAME THE LUBRIZOL CORPORATION (US) 2024-02-08 WO claimed
WO-2024030591-A1 PROCESSES FOR PRODUCING REACTION PRODUCTS INCLUDING QUATERNARY AMMONIUM SALTS THE LUBRIZOL CORPORATION (US) 2024-02-08 WO claimed
CN-112912438-B Curable compositions of elastomers 索尔维特殊聚合物意大利有限公司 2023-06-13 CN claimed
WO-2023014928-A1 PROCESSES FOR PRODUCING REACTION PRODUCTS OF POLYISOBUTYLENE AND AN ETHYLENICALLY UNSATURATED ACYLATING AGENT THE LUBRIZOL CORPORATION (US) 2023-02-09 WO claimed
EP-0043819-A4 EMULSION POLYMERIZATION PROCESS WITH LOW EMULSIFIER CONCENTRATION. GOODRICH CO B F (US) 1982-05-28 EP claimed
EP-0043819-A1 EMULSION POLYMERIZATION PROCESS WITH LOW EMULSIFIER CONCENTRATION. GOODRICH CO B F (US) 1982-01-20 EP claimed
WO-1981002158-A1 EMULSION POLYMERIZATION PROCESS WITH LOW EMULSIFIER CONCENTRATION GOODRICH CO B F (US) 1981-08-06 WO claimed
US-20260109105-A1 METHOD FOR PRODUCING STRETCHED FILM KANEKA CORPORATION (JP) 2026-04-23 US disclosed
US-20260060900-A1 DENTAL COMPOSITE RESIN KIT SHOFU INC. (JP) 2026-03-05 US disclosed
US-20260028469-A1 OPTICALLY RECOGNISABLE BIODEGRADABLE AND COMPOSTABLE COMPOSITION NOVAMONT S.P.A. (IT) 2026-01-29 US disclosed
EP-4444783-B1 MIXED ALIPHATIC-AROMATIC POLYESTERS NOVAMONT SPA (IT) 2026-01-28 EP disclosed
US-20260011738-A1 BINDER COMPOSITION FOR LITHIUM ION BATTERY ELECTRODES HARIMA CHEMICALS, INCORPORATED (JP) 2026-01-08 US disclosed
EP-0486277-B1 Process for catalyzing condensation reactions ROHM & HAAS (US) 1993-11-10 EP disclosed
WO-1983004032-A1 NOVEL FLUORODIOXOLES AND FLUORODIOXOLE POLYMERS E. I. DU PONT DE NEMOURS AND COMPANY (US) 1983-11-24 WO disclosed
EP-0056378-A4 AQEOUS SUSPENSIONS OF ORGANIC PEROXIDES. INTEROX CHEMICALS LTD (AU) 1982-11-08 EP disclosed
EP-0056378-A1 AQEOUS SUSPENSIONS OF ORGANIC PEROXIDES. INTEROX CHEMICALS LTD (AU) 1982-07-28 EP disclosed
WO-1982000104-A1 AQUEOUS SUSPENSIONS OF ORGANIC PEROXIDES LAAR H 1982-01-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260060900-A1 DENTAL COMPOSITE RESIN KIT BOLA2; BOLA2B, LBR, COL2A1 MAPT 2976/4885APOBEC3A 368/4885APOBEC3G 338/4885
US-20260109105-A1 METHOD FOR PRODUCING STRETCHED FILM TPM3, TPM4, HACD3 MAPT 1035/4885APOBEC3A 3901/4885APOBEC3G 3822/4885
US-20260028469-A1 OPTICALLY RECOGNISABLE BIODEGRADABLE AND COMPOSTABLE COMPOSITION DDT, CD68, HACD3 MAPT 2144/4885APOBEC3A 2958/4885APOBEC3G 3430/4885
US-20260011738-A1 BINDER COMPOSITION FOR LITHIUM ION BATTERY ELECTRODES ILK, LASP1, MMAB MAPT 1189/4885APOBEC3A 3098/4885APOBEC3G 2351/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.